160 related articles for article (PubMed ID: 38117668)
1. Improved Topical Ophthalmic Natamycin Suspension for the Treatment of Fungal Keratitis.
Cai C; Youssef AAA; Joshi PH; Varner C; Dudhipala N; Majumdar S
J Ocul Pharmacol Ther; 2024; 40(1):67-77. PubMed ID: 38117668
[No Abstract] [Full Text] [Related]
2. In vitro drug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials.
Phan CM; Subbaraman LN; Jones L
J Biomater Sci Polym Ed; 2014; 25(17):1907-19. PubMed ID: 25226305
[TBL] [Abstract][Full Text] [Related]
3. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole-Cyclodextrin Supramolecular Ternary Complex-Loaded Ocular Films for Management of Fungal Keratitis.
Suvarna P; Chaudhari P; Birangal S; Mallela LS; Roy S; Koteshwara A; Aranjani JM; Lewis SA
Mol Pharm; 2022 Jan; 19(1):258-273. PubMed ID: 34928610
[TBL] [Abstract][Full Text] [Related]
5. Carboxyvinyl Polymer and Guar-Borate Gelling System Containing Natamycin Loaded PEGylated Nanolipid Carriers Exhibit Improved Ocular Pharmacokinetic Parameters.
Patil A; Lakhani P; Taskar P; Avula B; Majumdar S
J Ocul Pharmacol Ther; 2020; 36(6):410-420. PubMed ID: 32315560
[No Abstract] [Full Text] [Related]
6. Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics.
Mascarenhas M; Chaudhari P; Lewis SA
Adv Ther; 2023 Aug; 40(8):3332-3359. PubMed ID: 37289410
[TBL] [Abstract][Full Text] [Related]
7. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
8. The preparation and therapeutic effects of β-glucan-specific nanobodies and nanobody-natamycin conjugates in fungal keratitis.
Liu X; Sui J; Li C; Wang Q; Peng X; Meng F; Xu Q; Jiang N; Zhao G; Lin J
Acta Biomater; 2023 Oct; 169():398-409. PubMed ID: 37579912
[TBL] [Abstract][Full Text] [Related]
9. Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.
Youssef AAA; Dudhipala N; Majumdar S
Int J Nanomedicine; 2022; 17():2283-2299. PubMed ID: 35611213
[TBL] [Abstract][Full Text] [Related]
10. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
[TBL] [Abstract][Full Text] [Related]
11. Antifungal Combination Eye Drops for Fungal Keratitis Treatment.
Díaz-Tomé V; Bendicho-Lavilla C; García-Otero X; Varela-Fernández R; Martín-Pastor M; Llovo-Taboada J; Alonso-Alonso P; Aguiar P; González-Barcia M; Fernández-Ferreiro A; Otero-Espinar FJ
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678663
[TBL] [Abstract][Full Text] [Related]
12. Nanocubosomal based
Hosny KM; Rizg WY; Alkhalidi HM; Abualsunun WA; Bakhaidar RB; Almehmady AM; Alghaith AF; Alshehri S; El Sisi AM
Drug Deliv; 2021 Dec; 28(1):1836-1848. PubMed ID: 34515597
[TBL] [Abstract][Full Text] [Related]
13. Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.
Sathe P; Kailasam V; Nagarjuna V; Sharma H; Velpandian T; Garg P; Nirmal J
Int J Pharm; 2024 May; 656():124118. PubMed ID: 38615806
[TBL] [Abstract][Full Text] [Related]
14. Novel water soluble sterile natamycin formulation (Natasol) for fungal keratitis.
Velpandian T; Nirmal J; Sharma HP; Sharma S; Sharma N; Halder N
Eur J Pharm Sci; 2021 Aug; 163():105857. PubMed ID: 33882328
[TBL] [Abstract][Full Text] [Related]
15. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
16. Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against
Sha X; Chan L; Fan X; Guo P; Chen T; Liu L; Zhong J
Int J Nanomedicine; 2022; 17():1463-1478. PubMed ID: 35378880
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
18. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
Prajna NV; Lalitha P; Krishnan T; Rajaraman R; Radnakrishnan N; Srinivasan M; Devi L; Das M; Liu Z; Zegans ME; Acharya NR; Porco TC; Lietman TM; Rose-Nussbaumer J
JAMA Ophthalmol; 2022 Feb; 140(2):179-184. PubMed ID: 35024776
[TBL] [Abstract][Full Text] [Related]
20. Electrospun formulation of acyclovir/cyclodextrin nanofibers for fast-dissolving antiviral drug delivery.
Celebioglu A; Uyar T
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111514. PubMed ID: 33255070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
